News provided by Eli Lilly and Company May 21, 2026, 06:45 ET In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss, a level long associated with bariatric surgery Individuals with a baseline BMI 35 who participated in a study extension continued to lose weight, and achieved up to an average of 85.0 lbs (30.3%) weight loss at 104 weeks At the 4 mg dose, reached with only a single escalation step, participants lost an average of 47.2 lbs (19.0%) at 80 weeks with a lower observed discontinuation rate due to adverse events vs
See the full vial-size math reference table above
doi: 10.1073/pnas.1316569111 58 ReboucheCJSeimH
Evening injection may reduce nausea during work hours, while morning injection gives you time to manage symptoms at home
According to certain investigations, consistent coffee intake could potentially increase insulin sensitivity in the long run
The study additionally showed that ROSE-010 was most helpful at relieving pain in IBS-C and IBS-M ( GLP-1 agonists, such as ROSE-010, relieve pain in IBS patients by altering gut motility ( in vitro and in vivo , GLP-1 has been frequently demonstrated to reduce GI muscle activity via nerve-mediated mechanisms reliant on nitric oxide (54, 55)